pmid	doi	year	title	Hugo_Symbol
34657128	10.1038/s41375-021-01448-2	2022	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.	BTG1
34791836	10.1002/cam4.4422	2022	Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.	BTG1
35401516	10.3389/fimmu.2022.842439	2022	Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.	BTG1
35459639	10.1016/j.bpj.2022.04.023	2022	Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants.	BTG1
35646048	10.3389/fgene.2022.878618	2022	Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.	BTG1
35774514	10.3389/fgene.2022.827840	2022	A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.	BTG1
35795062	10.3389/fonc.2022.870487	2022	Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis.	BTG1
35880434		2022	Emerging role of anti-proliferative protein BTG1 and BTG2.	BTG1
32467145	10.3324/haematol.2020.247973	2021	Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.	BTG1
33021411	10.1080/10428194.2020.1827243	2021	Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma.	BTG1
33777778	10.3389/fonc.2021.628807	2021	Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.	BTG1
34010787	10.1016/j.ejca.2021.03.034	2021	Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.	BTG1
34371436	10.1016/j.leukres.2021.106683	2021	Proposal and clinical application of molecular genetic risk scoring system, ""MRplus"", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.	BTG1
34599153	10.1038/s41419-021-04187-5	2021	Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.	BTG1
35116576	10.21037/tcr-20-2525	2021	Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database.	BTG1
32592278	10.1002/gcc.22882	2020	Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.	BTG1
32661308	10.1038/s41598-020-68311-9	2020	MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.	BTG1
33252851	10.1002/ctm2.221	2020	Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.	BTG1
33369444	10.31557/APJCP.2020.21.12.3493	2020	Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.	BTG1
30350856	10.1002/jcp.27407	2019	Tumor suppressors BTG1 and BTG2: Beyond growth control.	BTG1
30854058	10.3892/ol.2019.9900	2019	Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.	BTG1
30874617	10.1038/s41598-019-41078-4	2019	Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.	BTG1
31112375	10.1111/ijlh.13052	2019	Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.	BTG1
31228652	10.1016/j.leukres.2019.05.009	2019	Prognostic gene alterations and clonal changes in childhood B-ALL.	BTG1
29348129	10.1182/blood-2017-07-796862	2018	Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantation.	BTG1
29407587	10.1016/j.leukres.2018.01.012	2018	High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.	BTG1
29498923	10.1200/JCO.2017.74.3617	2018	IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.	BTG1
29786757	10.1007/s12185-018-2474-7	2018	Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.	BTG1
30203896	10.1002/gcc.22664	2018	Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.	BTG1
27339065	10.1080/10428194.2016.1193855	2017	Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.	BTG1
27979924	10.3324/haematol.2016.153023	2017	Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.	BTG1
28033648	10.1002/gcc.22439	2017	Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.	BTG1
28202519	10.1158/0008-5472.CAN-16-2571	2017	Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.	BTG1
28401483	10.1007/s12032-017-0940-3	2017	Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.	BTG1
28886309	10.14715/cmb/2017.63.8.4	2017	The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.	BTG1
28947432	10.1158/1940-6207.CAPR-17-0121	2017	<i>IKZF1</i> Gene in Childhood B-cell Precursor Acute Lymphoblastic Leukemia: Interplay between Genetic Susceptibility and Somatic Abnormalities.	BTG1
26657730	10.18632/oncotarget.6519	2016	Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.	BTG1
26781410		2016	[Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].	BTG1
26957068	10.3760/cma.j.issn.0578-1310.2016.03.011	2016	[Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia].	BTG1
27036158	10.3324/haematol.2015.139675	2016	Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development.	BTG1
27151989	10.3324/haematol.2016.143875	2016	Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.	BTG1
27229005	10.1182/blood-2016-03-704973	2016	Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.	BTG1
27959929	10.1371/journal.pmed.1002197	2016	Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.	BTG1
25571854	10.3892/ijmm.2014.2058	2015	B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.	BTG1
25710169	10.1371/journal.ppat.1004652	2015	HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism.	BTG1
25951811	10.1002/gcc.22251	2015	Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).	BTG1
24366360	10.1182/blood-2013-09-525808	2014	The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.	BTG1
24957142	10.1182/blood-2014-03-562918	2014	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.	BTG1
24998463	10.1016/j.cancergen.2014.05.003	2014	High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.	BTG1
25044358	10.1002/gcc.22201	2014	Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.	BTG1
25117713	10.1016/j.ccr.2014.06.014	2014	MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.	BTG1
25173640	10.1007/s13277-014-2298-x	2014	Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.	BTG1
22868968	10.1038/leu.2012.199	2013	BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.	BTG1
22072402	10.1002/gcc.20944	2012	High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.	BTG1
22343534	10.1073/pnas.1121343109	2012	Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.	BTG1
22359517	10.1371/journal.pgen.1002533	2012	The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.	BTG1
22851563	10.1200/JCO.2011.40.3907	2012	IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.	BTG1
20354172	10.1182/blood-2009-05-223081	2010	BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.	BTG1
17374122	10.1111/j.1349-7006.2007.00443.x	2007	Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.	BTG1
17466295	10.1016/j.yexcr.2007.03.021	2007	Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.	BTG1
17485552	10.1182/blood-2006-12-064865	2007	Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.	BTG1
11920564	10.1002/1521-4141(200204)32:4&lt;982::AID-IMMU982&gt;3.0.CO;2-I	2002	Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays.	BTG1
